The maize lethal necrosis (MLN) artificial inoculation screening site in Naivasha, Kenya, will begin its phenotyping (screening/ indexing) cycle of 2019 at the beginning of January 2019 and in other four intervals throughout the year. Interested organizations from both the private and public sectors are invited to send maize germplasm for screening.
Experts discuss agricultural research and food security at the 2018 Borlaug Dialogue.
The maize lethal necrosis (MLN) artificial inoculation screening site in Naivasha, Kenya will begin its phenotyping (screening/ indexing) cycle of 2018 at the begining of January 2018 and in four other intervals.
The maize lethal necrosis screening site in Kenya will begin its second screening cycle of 2017 at the end of October.
Plant pathology expert Monica Mezzalama shares on keeping biosafety and seed health in check at CIMMYT.
Scientists involved in a major global initiative aimed at increasing wheat yields as much as 60 percent by 2050 get a boost from U.S. government announcement of new research funds.
PLC6 is a term used to refer to an advanced stage of hybrid testing at Syngenta, a partner of the Affordable, Accessible, Asian (AAA) Drought Tolerant Maize Project. Four hybrids, representing combinations of Syngenta and CIMMYT germplasm are currently at PLC6 in big plots at multiple locations. The trajectory of this process points to pilot marketing of a limited quantity of hybrid seed in 2016 and a full market launch in 2017.
Policies designed to promote maize industry growth require data and information, which is often difficult to obtain in Asian countries. This was discussed during the technical session on improving maize seed systems in Asia at the 12th Asian Maize Conference.
Partners of the Maize Lethal Necrosis (MLN) project in Africa, funded by the Bill & Melinda Gates Foundation and Syngenta Foundation for Sustainable Agriculture (SFSA), came together to review and discuss the progress and next steps for the project at a workshop on 14-15 May.